Understanding thrombotic microangiopathies in children

Intensive Care Med. 2018 Sep;44(9):1536-1538. doi: 10.1007/s00134-018-5059-2. Epub 2018 Jan 24.
No abstract available

Publication types

  • Review

MeSH terms

  • ADAMTS13 Protein / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Child
  • Fibrinolytic Agents / therapeutic use
  • Hemolytic-Uremic Syndrome / drug therapy
  • Hemolytic-Uremic Syndrome / etiology*
  • Humans
  • Thrombotic Microangiopathies / drug therapy
  • Thrombotic Microangiopathies / etiology*

Substances

  • Antibodies, Monoclonal, Humanized
  • Fibrinolytic Agents
  • eculizumab
  • ADAMTS13 Protein
  • ADAMTS13 protein, human